The worldwide biotechnology space has entered a highly diversified stage. The technology has expanded the scope of science along with creating innovative opportunities in a wide range of industries, including gene technologies, applied immunology, genomics, and many others. Besides, pharmacological therapies and diagnostic services have reached an advanced stage relying on biotechnology.
Technology has expanded the field of science and created new opportunities in areas like applied immunology, recombinant gene technologies, and genomics. Diagnostic procedures and pharmacological therapies are both developed using biotechnology.
READ MORE: Edtech and Smart Classroom Industry in North America: Market Drivers and Forecast
The US biotechnology market is anticipated to expand rapidly during the forecast period (i.e, from 2020 to 2026) with a CAGR of 7.4%. The US biotechnology market was estimated to be worth $200 billion in 2019 and is anticipated to expand rapidly over the suggested period. Such an expansion enjoys the support of a highly sophisticated and well-developed healthcare system, home to numerous research institutions specializing predominantly in stem cell studies.
Governing bodies also extend continuous support. Additionally, government organizations like the NSF and DARPA have shown interest in large-scale integrated programs to investigate novel approaches to sustainable development.
READ MORE: True Religion Customers Now Have An Innovative Mobile APP for Better Experience
Additionally, several stem cell research institutions have been concentrating on conducting research employing cell harvesting techniques. In terms of public research financing, the US is the biggest investor, and the nation is all set to enhance its commitment to keep up with worldwide trends.